StonvexLoading…
StonvexStonvexStonvexCore line items from CR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.31B | $2.13B | $1.86B | $1.78B |
Operating Income | $424.20M | $355.80M | $250.40M | $5.30M |
Net Income | $366.60M | $294.70M | $255.90M | $401.10M |
EPS (Diluted) | $6.26 | $5.05 | $4.45 | $7.01 |
Total Assets | $3.85B | $2.64B | $2.35B | $4.39B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $506.50M | $306.70M | $329.60M | $427.00M |
Free Cash Flow OCF − CapEx | $341.30M | $221.20M | $123.10M | $-532.10M |
Shares Outstanding | 57.61M | 57.29M | 56.92M | 56.33M |